Searchable abstracts of presentations at key conferences in endocrinology

ea0011p326 | Diabetes, metabolism and cardiovascular | ECE2006

The effect of moxonodine on endothelial dysfunction in metabolic syndrome

Cikim Ayse Sertkaya , Topal Ergun , Cikim Kerim , Temel Ismail , Ozdemir Ramaza

Introduction: Metabolic syndrome (MS) is a clustering of risk factors. Endothelial dysfunction has been reported in patients with MS and even in healthy obese individuals with a normal metabolic profile. Sympathetic activity commonly is increased in obese hypertensives, and moxonidine, is found to be effective in lowering blood pressure and improving insulin sensitivity. The aim of this study is to evaluate the efficacy of moxonidine on endothelial dysfunction in insulin-resis...

ea0035p118 | Calcium and Vitamin D metabolism | ECE2014

The relationship with plasma calcium levels, metabolic syndrome, and risk parameters in overweight and obese Turkish women

Ipek Emel , Ucer Mehtap , Cikim Ayse , Tanyolac Sinan

Introduction: Obesity prevalance is rapidly increasing all over the world and become a serious health problem. There is a significant correlation between serum calcium levels and body fat mass. It was indicated that when plasma calcium levels increase, BMI decrease however, insulin, total cholesterol, and triglycerides levels increase. In this study, it was investigated the relationship between plasma calcium levels and cardiovascular risk factors and metabolic syndrome parame...

ea0035p1106 | Thyroid Cancer | ECE2014

The role of DNA repair proteins in the assessment of thyroid nodules

Evren Bahri , Karadag Nese , Yilmaz Sami , Sertkaya Ayse Cikim

Aims: Bening and malignant thyroid nodules are the most common lesions of endocrine glands. Some molecular markers; Mut-S homolog-2 (MSH2) and Mut-L-homolog-1 (MLH1) are the two of DNA repair proteins and metil guanin–DNA-metil transferase (MGMT) is the DNA repair enzymes have been studied. In this study, our aim is to evaluate MSH2, MLH1, and MGMT levels in papillary thyroid cancer (PTC), multinodular colloidal goitre (MNG), and chronic lymphocytic thyroiditis (CLT) and ...

ea0014p242 | (1) | ECE2007

Uric acid is an important predictor of metabolic disturbances in obese women

Cikim Ayse Sertkaya , Bayraktaroglu Taner , Azezli Adil Dogan , Orhan Yusuf

Introduction: It was shown that a relationship between uric acid and cardiovascular diseases, and hyperuricemia is associated with systemic inflammation. But, determination of uric acid is widely available and inexpensive, it has been overlooked as a marker of systemic inflammation and metabolic disturbances. In this study, we aimed to evaluate uric acid value and its association with inflammation and metabolic disturbances in overweight and obese Turkish women.<p class="a...

ea0014p400 | (1) | ECE2007

Relationship between antropometric and metabolic parameters and parathyroid hormone levels in women

Cikim Ayse Sertkaya , Bayraktaroglu Taner , Azezli Adil Dogan , Orhan Yusuf

Aim: Increased levels of fasting parathyroid hormone(PTH) have been hypothesized to influence increased levels of body fat mass. Preliminary studies show that serum PTH levels are higher in obese than in non-obese young adults and decline with weight loss. In the present study, it was aimed to evaluate relationship between antropometric and metabolic risk parameters and PTH levels in Turkish women.Materials and methods: Analyses were performed on 710 Tur...

ea0014p401 | (1) | ECE2007

Serum calcium levels and metabolic disturbances in obese women

Bayraktarogl Taner , Cikim Ayse Sertkaya , Azezli Adil Dogan , Orhan Yusuf

Aim: Serum calcium levels have a relation glucose homeostasis and weight management, and controversies in findings. This study carried out relationship between serum calcium levels and various metabolic parameters in obese Turkish Women.Materials and methods: Subjects for this study were 3544 overweight or obese Turkish women with mean level of serum calcium 9.4 md/dl. According to mean calcium level, they divided group I having >9.4 mg/dl and group ...

ea0014p635 | (1) | ECE2007

Age at menarche in relation to adult obesity

Bayraktaroglu Taner , Sertkaya Cikim Ayse , Dogan Azezli Adil , Orhan Yusuf

Introduction: Age at menarche reflects various health aspects including the timing of sexual maturation, growth and nutritional status, and enviromental conditions. This study carried out assesment obesity risk and the relationship between obesity, metabolic parameters and age at menarche in a series of Turkish women.Materials and methods: In a survey of obesity outpatient clinic, 4212 women who have mean age 38.5±12.1 years and ages at menarche bet...

ea0011p319 | Diabetes, metabolism and cardiovascular | ECE2006

Effects of Ezetimibe on serum lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL cholesterol apheresis and high dose atorvastatin therapy

Azezli A , Bayraktaroglu T , Kutluturk F , Cikim A , Tanyolac S , Orhan Y

Homozygous familial hypercholesterolemia (HoFH) represents a potentially fatal condition that is caused by low density lipoprotein (LDL) cholesterol receptor deficiency. Statins alone are not effective in HoFH. In recent years, semiselective or selective LDL cholesterol apheresis systems have been shown to prolong life. However, applying LDLC apheresis therapy, recent evidence also suggests that more intense LDL cholesterol reduction is associated with more clinical benefit. E...

ea0011p320 | Diabetes, metabolism and cardiovascular | ECE2006

Effect of micronised fenofibrate on plasma levels of c-reactive protein in combined hyperlipidemia

Azezli A , Bayraktaroglu T , Kutluturk F , Cikim A , Tanyolac S , Orhan Y

C-reactive protein (CRP) is a non-specific but sensitive marker of underlying systemic inflammation. High CRP levels correlate with risk for future cardiovascular events. Statins can lower the circulating levels of CRP. In contrast, the evidence that fibrates lower CRP levels is very limited. This retrospective study evaluates the effect of micronised fenofibrate on plasma levels of CRP in patients with combined hyperlipidemia.Sixty-four patients with co...

ea0011p323 | Diabetes, metabolism and cardiovascular | ECE2006

Serum ferritin levels and obesity

Kutluturk Faruk , Cikim Ayse Sertkaya , Azezli Adil , Orhan Yusuf

Introduction: Serum ferritin concentration was found to be related with dyslipidemia, hypertension and abdominal adiposity. The aim of this study is to evaluate the correlations between serum ferritin concentrations and metabolic risk markers in obesity.Methods: Obese 534 women were enrolled into the study. The patients were divided into three tertiles according to the serum ferritin concentrations. The mean serum ferritin concentration was 9.96±4.1...